Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus

被引:106
|
作者
Hobbs, Joanne Karen
Miller, Keith
O'Neill, Alex John
Chopra, Ian [1 ]
机构
[1] Univ Leeds, Antimicrobial Res Ctr, Leeds LS2 9JT, W Yorkshire, England
基金
英国生物技术与生命科学研究理事会;
关键词
membrane potential; macromolecular synthesis; S; aureus;
D O I
10.1093/jac/dkn321
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The proposed lethal action of daptomycin on Staphylococcus aureus results from the loss of K+ and membrane depolarization. However, whether these events alone cause cell death has been questioned. We sought to determine whether other consequences of daptomycin-mediated membrane damage may contribute to cell death. Methods: Previously established assays were used to evaluate the membrane damaging activity of daptomycin at a single time-point of 10 min. More detailed time-course experiments were also performed to determine the kinetics of membrane depolarization and leakage of K+, Mg2+ and ATP. The kinetics of inhibition of macromolecular synthesis following exposure to daptomycin were also determined by assaying the incorporation of radioactive precursors into macromolecules. Results: Daptomycin exhibited no membrane damaging activity in single time-point assays following exposure to the antibiotic for 10 min. Kinetic analysis confirmed these results as leakage of intracellular components did not occur until 20-30 min, membrane depolarization was gradual and cells remained biosynthetically active for at least 30 min after exposure to daptomycin. Viability declined rapidly after exposure to daptomycin and appeared to precede other detectable changes. Conclusions: These data show that daptomycin-induced loss of Mg2+ and ATP occurs in conjunction with the previously reported leakage of K+ and membrane depolarization. We propose that the lethal activity of daptomycin is not simply due to loss of K+ and probably involves more general damage to the membrane.
引用
收藏
页码:1003 / 1008
页数:6
相关论文
共 50 条
  • [31] Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In Vivo
    Weiss, Elizabeth C.
    Zielinska, Agnieszka
    Beenken, Karen E.
    Spencer, Horace J.
    Daily, Sonja J.
    Smeltzer, Mark S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4096 - 4102
  • [32] Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
    Yang, Soo-Jin
    Xiong, Yan Q.
    Dunman, Paul M.
    Schrenzel, Jacques
    Francois, Patrice
    Peschel, Andreas
    Bayer, Arnold S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (06) : 2636 - 2637
  • [33] Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus
    Cotroneo, Nicole
    Harris, Robert
    Perlmutter, Nancy
    Beveridge, Terry
    Silverman, Jared A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) : 2223 - 2225
  • [34] Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus
    Ma, Zhuo
    Lasek-Nesselquist, Erica
    Lu, Jackson
    Schneider, Ryan
    Shah, Riddhi
    Oliva, George
    Pata, Janice
    McDonough, Kathleen
    Pai, Manjunath P.
    Rose, Warren E.
    Sakoulas, George
    Malik, Meenakshi
    PLOS ONE, 2018, 13 (06):
  • [36] High-dose daptomycin in documented Staphylococcus aureus infections
    Bassetti, Matteo
    Nicco, Elena
    Ginocchio, Francesca
    Ansaldi, Filippo
    de Florentiis, Daniela
    Viscoli, Claudio
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (05) : 459 - 461
  • [37] Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis
    Parlato, Ciro
    di Nuzzo, Giuseppe
    Luongo, Marianna
    Esposito, Silvano
    Moraci, Aldo
    NEUROLOGICAL SCIENCES, 2011, 32 (04) : 747 - 748
  • [38] The use of daptomycin for Staphylococcus aureus infections in critical care medicine
    Alder, Jeffrey
    CRITICAL CARE CLINICS, 2008, 24 (02) : 349 - +
  • [39] Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin
    Skiest, DJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) : 655 - 656
  • [40] The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species
    Richter, SS
    Kealey, DE
    Murray, CT
    Heilmann, KP
    Coffman, SL
    Doern, GV
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 123 - 127